Could a zappy headband save your sight? stanford tests new glaucoma device
NCT ID NCT06685211
First seen Nov 05, 2025 · Last updated Jun 23, 2026 · Updated 25 times
Summary
This study tests whether a device called Eyetronic, which delivers mild electrical pulses through the eyes, can help people with glaucoma. Glaucoma damages the optic nerve and can lead to vision loss. The trial will compare the active device to a sham (fake) version in 30 adults with moderate glaucoma. Researchers will measure changes in vision and eye structure over three months to see if the stimulation helps protect sight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Byers Eye Institute at Stanford University
RECRUITINGPalo Alto, California, 94303, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Eyetronic rtACS device (non-invasive electrical stimulation)
What this could lead to
If it works, this could offer a new, non-invasive way to slow vision loss and preserve sight in people with glaucoma.
What could go wrong
This is a very small early-stage trial with only 30 people, so results may not apply to everyone. The treatment is also compared to a sham device, so any benefit might be small or due to a placebo effect.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.